Virongy Biosciences

Virongy Biosciences develops advanced virology research platforms and diagnostic technologies. Their commercialized offerings include rapid quantitative SARS-CoV‑2 neutralization assays, viral pseudotype systems covering multiple high-risk pathogens, custom peptide synthesis services, cell line engineering solutions ("Cellment"), the "Infectin" transduction enhancer reagent/platform, as well as proprietary lentiviral vector systems. Their products are used by academic labs and industry partners globally to accelerate antiviral drug discovery and vaccine development. They do not have clinical-stage therapeutics but provide essential enabling technologies that support preclinical through translational infectious disease R&D.